Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis

Rheumatology International

Volumn 35, Issue 1, 2015, Pages 71-79

  Chang, Sung Hae ^a   Choi, Byoong Yong ^b,c   Choi, Jungbum ^d   Yoo, Jong Jin ^e   Ha, You Jung ^d   Cho, Hyon Joung ^d   Kang, Eun Ha ^d   Song, Yeong Wook ^b   Lee, Yun Jong ^b,d  

^a Soonchunhyang University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul Medical Center   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e Kangdong Sacred Heart Hospital   (South Korea)

Author keywords

Ankylosing spondylitis; Disease progression; Interleukin 34; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CD68 ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; INTERLEUKIN 34; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, HUMAN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BONE EROSION; CONTROLLED STUDY; DAS28; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT CAVITY; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; SHARP VAN DER HEIJDE SCORE; SMOKING; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE; SYNOVIUM; AGED; BLOOD; DISEASE COURSE; FOOT; HAND JOINT; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; RADIOGRAPHY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; FOOT JOINTS; HAND JOINTS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SPONDYLITIS, ANKYLOSING;

EID: 84926616811     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3056-5     Document Type: Article

References (33)

1. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373:659-672. doi:10.1016/S0140-6736(09)60008-8
2. Fex E, Jonsson K, Johnson U, Eberhardt K (1996) Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 35:1106-1115
3. Upchurch KS, Kay J (2012) Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 6):vi28-vi36. doi:10.1093/rheumatology/kes278
4. Emery P, Gabay C, Kraan M, Gomez-Reino J (2007) Evidencebased review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 27:793-806
5. Mease PJ (2011) The potential roles for novel biomarkers in rheumatoid arthritis assessment. Clin Exp Rheumatol 29:567-574
6. Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DM, van der Linden S, Boers M (2006) The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 54:1772-1777
7. Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, Halenbeck R, Wu G, Zhou A, Behrens D, Hollenbaugh D, Linnemann T, Qin M, Wong J, Chu K, Doberstein SK, Williams LT (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320:807-811. doi:10.1126/ science.1154370
8. Chemel M, Le Goff B, Brion R, Cozic C, Berreur M, Amiaud J, Bougras G, Touchais S, Blanchard F, Heymann MF, Berthelot JM, Verrecchia F, Heymann D (2012) Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis 71:150-154. doi:10.1136/annrheum dis-2011-200096
9. Hwang SJ, Choi B, Kang SS, Chang JH, Kim YG, Chung YH, Sohn DH, So MW, Lee CK, Robinson WH, Chang EJ (2012) Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res Ther 14:R14. doi:10.1186/ar3693
10. Moon SJ, Hong YS, Ju JH, Kwok SK, Park SH, Min JK (2013) Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis. J Rheumatol 40:1842-1849. doi:10.3899/jrheum.130356
11. Tian Y, Shen H, Xia L, Lu J (2013) Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production. J Interferon Cytokine Res 33:398-401. doi:10.1089/ jir.2012.0122
12. Eda H, Shimada H, Beidler DR, Monahan JB (2011) Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 m RNA via JNK-and p44/42 MAPK-NF-kappa B pathway but not p38 pathway in osteoblasts. Rheumatol Int 31:1525-1530. doi:10.1007/s00296-010-1688-7
13. Eda H, Zhang J, Keith RH, Michener M, Beidler DR, Monahan JB (2010) Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine 52:215-220. doi:10.1016/j.cyto.2010.08.005
14. Baud'huin M, Renault R, Charrier C, Riet A, Moreau A, Brion R, Gouin F, Duplomb L, Heymann D (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol 221:77-86. doi:10.1002/path.2684
15. Chen Z, Buki K, Vääräniemi J, Gu G, Väänänen HK (2011) The critical role of IL-34 in osteoclastogenesis. PLo S ONE 6:e18689. doi:10.1371/journal.pone.0018689
16. Boström EA, Lundberg P (2013) The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. PLo S ONE 8:e81665. doi:10.1371/ journal.pone.0081665
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
18. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
19. van der Heijde D (1999) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 26:743-745
20. Grandaunet B, Syversen SW, Hoff M, Sundan A, Haugeberg G, van Der Heijde D, Kvien TK, Standal T (2011) Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis. Arthritis Rheum 63:662-669. doi:10.1002/ art.30163
21. Kawaji H, Yokomura K, Kikuchi K, Somoto Y, Shirai Y (1995) Macrophage colony-stimulating factor in patients with rheumatoid arthritis. Nihon Ika Daigaku Zasshi 62:260-270
22. Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC (2008) Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum 58:2257-2267. doi:10.1002/art.23667
23. Zhang W, Cong XL, Qin YH, He ZW, He DY, Dai SM (2013) IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 36:103-109. doi:10.1007/s10753-012-9524-8
24. Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM, Sharpe O, Roscow C, Ho PP, Lee DM, Robinson WH (2010) c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis. Arthritis Res Ther 12:R32. doi:10.1186/ar2940
25. Toh ML, Bonnefoy JY, Accart N, Cochin S, Pohle S, Haegel H, De Meyer M, Zemmour C, Preville X, Guillen C, Thioudellet C, Ancian P, Lux A, Sehnert B, Nimmerjahn F, Voll RE, Schett G (2014) A CSF-1 receptor monoclonal antibody has potent bone and cartilage protective effects in experimental arthritis. Arthritis Rheumatol. doi:10.1002/art.38624
26. Chitu V, Stanley ER (2006) Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18:39-48
27. Ciccia F, Alessandro R, Rodolico V, Guggino G, Raimondo S, Guarnotta C, Giardina A, Sireci G, Campisi G, De Leo G, Triolo G (2013) IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes. Rheumatology (Oxford) 52:1009-1017. doi:10.1093/ rheumatology/kes435
28. Li Z, Jin D, Wu Y, Zhang K, Hu P, Cao X, Chen Z (2012) Increased serum interleukin-34 in patients with coronary artery disease. J Int Med Res 40:1866-1870
29. Nakao K, Kubota S, Doi H, Eguchi T, Oka M, Fujisawa T, Nishida T, Takigawa M (2005) Collaborative action of M-CSF and CTGF/CCN2 in articular chondrocytes: possible regenerative roles in articular cartilage metabolism. Bone 36:884-892
30. Nakamichi Y, Udagawa N, Takahashi N (2013) IL-34 and CSF-1: similarities and differences. J Bone Miner Metab 31:486-495. doi:10.1007/s00774-013-0476-3
31. Barve RA, Zack MD, Weiss D, Song RH, Beidler D, Head RD (2013) Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiation. Cytokine 63:10-17. doi:10.1016/j.cyto.2013.04.019
32. Seitz M, Loetscher P, Fey MF, Tobler A (1994) Constitutive m RNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol 33:613-619
33. Combe B (2009) Progression in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 23:59-69. doi:10.1016/j.berh.2008.11.006